XRAY vs CHRW
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
XRAY
CHRW
Investment Advisor Scores
CHRW
AI Analyst Insights
Detailed Metrics Comparison
| Metric | XRAY | CHRW | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.4392 | 17.5439 | XRAY |
| PEG Ratio | 0.6439 | 1.4984 | XRAY |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -7.5% | 29.5% | CHRW |
| Earnings Growth | 15.2% | 24.6% | CHRW |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.0/100 | 64.4/100 | CHRW |
| Profit Margin | -3.4% | 3.7% | CHRW |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG BUY | CHRW |
Relative Price Performance (Last 90 Days)
Current Technical Phase
XRAY
NeutralMixed signals - no dominant trend phase, RSI 53
CHRW
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | XRAY | CHRW |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.8 | 17.9 |
| Trailing P/E | — | 23.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.3% |
| Gross Margin | 0.5% | 0.1% |
| Operating Margin | 0.0% | 0.1% |
| EPS | -0.61 | 5.57 |
| Dividend Yield | 0.02% | 0.02% |